UCAM researcher will study new advances against colorectal cancer in New York
She has won one of the 16 Fulbright grants awarded by the US to Spain to achieve new advances against this tumour, which has the second highest mortality rate in the world
Molecular medicine to individualise the treatment of metastatic cancer
UCAM has created Spain's first chair in this discipline, directed by Dr Fernando Vidal Vanaclocha, who describes the work he is carrying out in this interview.
An existing drug may block metastases in colorectal cancer
The development of this patent has been possible thanks to the study carried out by UCAM and the IMIB to find new drugs that act by reducing the migration and invasion of tumour cells